Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Nov 15, 2019; 11(11): 1011-1020
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1011
Table 2 20-point data set observation of the study cohorts, n (%)
Early-onset CRCLater-onset CRCControl
N57106301011800420
Gender
Male2800 (49)32320 (51)4931130 (42)
Female2910 (51)30690 (49)6869290 (58)
Ethnicity
Caucasian3880 (68)52330 (83)6947160 (59)
African-American860 (15)8260 (13)1462790 (12)
Asian110 (2)1380 (2)258990 (2)
Symptoms
Abdominal pain3060 (54)24490 (39)2317490 (20)
Rectal pain170 (3)1260 (2)48200 (0.4)
Altered bowel function1440 (25)14610 (23)680420 (6)
Rectal bleeding790 (14)7960 (13)190310 (2)
Weight loss490 (9)7800 (12)147250 (1)
Family history
Of cancer1360 (24)9400 (15)308120 (3)
Of GI malignancy840 (15)4300 (7)70560 (1)
Of polyps60 (1)470 (1)15350 (0.1)
Social history
Tobacco use3600 (63)42360 (67)4838172 (41)
Alcohol use2000 (35)24850 (39)2832100 (24)
Comorbidities
Colitis710 (12)7270 (12)395260 (3)
BMI ≥ 303510 (61)36770 (58)4202120 (35)
Hypertension1710 (30)41740 (66)1534060 (13)
Hyperlipidemia1090 (19)33960 (54)1062040 (9)
Polyp history630 (11)8970 (14)155640 (1)